Therapeutic Group: Respiratory Presentation Each bottle contains 120 metered doses of Budesonide BP. Each actuation delivers Budesonide BP 100 mcg. Description Budesonide is a synthetic corticosteroid having potent glucocorticoid activity and weak mineralocorticoid activity. It has approximately a 200-fold higher affinity for the glucocorticoid receptor and a 1000-fold higher topical anti-inflammatory potency than cortisol. Corticosteroids […]
Therapeutic Group: Respiratory Presentation Mucolyt Tablet: Each tablet contains Bromhexine Hydrochloride BP 8 mg. Mucolyt 100 ml Syrup: Each 5 ml syrup contains Bromhexine Hydrochloride BP 4 mg. Mucolyt 200 ml Syrup: Each 5 ml syrup contains Bromhexine Hydrochloride BP 4 mg. Description Mucolyt is a highly effective mucolytic expectorant. Indications Mucolyt is indicated in […]
Therapeutic Group: Ophthalmic Presentation Xibrofen® sterile eye drops: Each ml of contains Bromfenac Sodium INN equivalent to 0.9 mg Bromfenac. Description Bromfenac 0.09% is a sterile, topical, nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. Indications This medication is used […]
Therapeutic Group: Drugs of Nervous System Presentation Siesta: Each tablet contains Bromazepam USP 3 mg. Description Siesta is a pyridylbenzodiazepine compound with anxiolytic properties. In low dosage, it diminishes anxiety, tension and nervousness. In high dosage, the sedative and muscle-relaxant properties appear. Indications Siesta is indicated in the following diseases: * Emotional disturbances: Anxiety and […]
Therapeutic Group: Drugs of Nervous System, Antiepileptic Presentation Epicure 25 Tablet: Each tablet contains Brivaracetam INN 25 mg. Epicure 50 Tablet: Each tablet contains Brivaracetam INN 50 mg. Epicure Oral Solution: Each 5 ml solution contains Brivaracetam INN 50 mg. Epicure 50 Injection: Each 5 ml injectable solution contains Brivaracetam INN 50 mg. Description The […]
Therapeutic Group: Ophthalmic Presentation Zolamid Plus Sterile Ophthalmic Suspension: Each ml contains Brinzolamide USP 10 mg and Brimonidine Tartrate BP 2 mg. Description Zolamid Plus is a combination of a carbonic anhydrase inhibitor, brinzolamide and an alpha 2 adrenergic receptor agonist, brimonidine tartrate. Each of these two components decreases elevated intraocular pressure. Brinzolamide inhibits carbonic […]
Therapeutic Group: Ophthalmic Presentation Zolamid Sterile Ophthalmic Suspension: Each ml contains Brinzolamide USP 10 mg Description Brinzolamide is a carbonic anhydrase II (CA-II) inhibitor that inhibits aqueous humor production to reduce elevated intraocular pressure. Indications Zolamid Sterile Ophthalmic Suspension is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle […]
Therapeutic Group: Anti Glaucoma Presentation Brimodin Plus Sterile Eye Drops: Each ml contains Brimonidine Tartrate INN 2 mg and Timolol Maleate USP equivalent to Timolol 5 mg. Description Brimodin Plus is a combination preparation of selective alpha-2 adrenergic receptor agonist, brimonidine and a non-selective beta-adrenergic receptor inhibitor, timolol. Fluorophotometric studies in animals and humans suggest […]
Therapeutic Group: Ophthalmic- Antiglaucoma Presentation Each ml contains Brimonidine Tartrate INN 2 mg. Description Brimodin contains the active ingredient brimonidine. It is a relatively selective alpha-2 adrenergic receptor agonist and approximately 1000 times more selective for the alpha-2 adrenoceptor than the alpha-1 adrenoceptor. Topical administration of brimonidine decreases intraocular pressure (IOP) in humans. When used […]
Therapeutic Group: Anti Cancer Presentation Brigacent 90: Each film coated tablet contains Brigatinib INN 90 mg. Brigacent 180: Each film coated tablet contains Brigatinib INN 180 mg. Description Brigatinib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks both anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). Indications Brigatinib is […]